Are nootropics getting so big that they are finally becoming “mainstream?” It seems as though that might well be the case. The nootropic industry is about to hit $30 billion in online revenue. It’s growing at a drastic, furious pace. And it is showing few signs of slowing down. My best nootropics list has grown ten-fold over the course of the past few years (remember, this supplement review site largely focused on other supplement genres). But nootropic searches online are at an all time high. All of this is due to the fact that nootropics work, which is something I’ve been preaching for years.
Nootrobox/HVMN CEO Geoff Woo boldly claims that nootropics can take us mere mortals to places we’d otherwise not be able ot go, according to an article in wndu.
“Typical vitamins focus on micro nutrients, so these things are deficiencies in a person’s normal diet,” he said. “What we look at our company is looking at things that can enhance human performance.”
In the same article, Coleman Maher, a wrestler, claims that his athletic and mental performances are both elevated by using nootropics.
“It’s a really, really tough grind and it’s hard to stay focused or motivated sometimes,” Maher said. “So, having an energy boost is very valuable.”
To the general public, nootropics remain a confusing, and in some cases, demonized supplement line. Piracetam is one of the most popular nootropics around, as is Noocube. Piracetam is not legally sold in Europe without a prescription making the United States a hotbed for it’s use. Many doctors feel that consumers jump too fast at nootropics, and while we definitely encourage nootropic use, we also recommend that potential consumers speak to a medical professional before taking them.
Nootropics Are Taking Over Silicon Valley
Silicon Valley elites and executives are well-known for doing anything to gain an edge. The HBO hit-show, Silicon Valley, satirically approaches the matter often in their scripts.
But in terms of comedy writing, the truth may be closer to the fiction they portray. Yahoo’s Marissa Mayer is known to be invested in the nootropic vertical. Both she and Zynga CEP Mark Pincus invested a half a million dollars into Woo’s Nootrobox. It doesn’t hurt that Woo and Mayer run in the same Silicon Valley circles, but it also doesn’t hurt that nootropic reviews are increasingly outstanding.
Consumers are turning to nootropics as a way to get an edge and not always in executive level tasks. Nootropics can help a secretary type more words per minute, which could result in his or her work earlier and either going home, or soaking up some Facebook.
Nootropics were discovered accidentally in the 1960’s when researchers were attempting to find a cure for motion sickness. Instead, they stumbled on a way for people to achieve a higher level of concentration and focus, with many reporting increased memory ability. It was piracetam that came along more formally in the 1970s and somewhat legitimized the science. But nootropics have also had their share of rocky times, including the past decade when truck stop ephedrine based products came under condemnation. And that’s the stigma nootropics are looking to shake off and they march into what seems like a massive financial upswing.
All the same, the trend is being driven by consumers, not marketers. Consumers are looking for brain pills that work and they are finding them and telling their friends about them. That’s a healthy business process.
